Skip to content

The effect of mindfulness-based interventions on immunity-related biomarkers: a comprehensive meta-analysis of randomised controlled trials.

Thomas J. Dunn, Mirena Dimolareva

Clinical Psychology Review March 2022 DOI: 10.1016/j.cpr.2022.102124 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Meta-analysis of randomized controlled trials Peer reviewed
Sample size 4,683
Population Participants in randomized controlled trials of mindfulness-based interventions across varied study populations
Intervention Mindfulness-based interventions
Measures CD4+ cells, C-reactive protein, interleukin-6, nuclear factor-κB, telomere length, telomerase activity
Topics Meditation
Keywords Biomarkers C-reactive protein Cd4 Crp Il-6 Immune function Immunity Inflammatory Interleukin Mbi Mindfulness-based Telomeres
Key findings Pooled across 48 randomized trials, mindfulness-based interventions were associated with lower C-reactive protein (SMCD = -0.14) and interleukin-6 (SMCD = -0.35), and higher CD4+ cells (SMCD = 0.09), telomere length (SMCD = 0.12), and telomerase activity (SMCD = 0.81) at post-intervention. At follow-up, interleukin-6 (SMCD = -0.13) and C-reactive protein (SMCD = -0.39) remained reduced and CD4+ cells increased (SMCD = 0.22). The authors argue these results quantify the potential of mindfulness-based interventions to improve immune function and affect somatic disorders.

Abstract

One proposed pathway that mindfulness-based interventions (MBIs) may offer a salutogenic effect on somatic disorders is by enhancing immune function. As such, we conducted a meta-analysis of randomised controlled trials examining the effect of MBIs at post-intervention and follow-up for six immune-related biomarkers, including CD4+ cells, C-reactive protein, interleukin-6, nuclear factor-κB, telomere length, and telomerase activity. Potential studies were identified by searching ScienceDirect, Web of Science, Academic Search Complete, AMED, MEDLINE, PsycARTICLES, and PsycINFO. Searches returned 1959 studies, of which 48 (70 effects) were included (N = 4683). Pooled effect sizes indicated a reduction in C-reactive protein (SMCD = -.14, 95% CI [-.26 - -.01]) and interleukin-6 (SMCD = -.35, 95% CI [-.67 - -.03]), and an increase in CD4+ (SMCD = .09, 95% CI [-.05 - .22]), telomere length (SMCD = .12, 95% CI [.00 - .24]) and telomerase activity (SMCD = .81, 95% CI [.17 - 1.46]) at post-intervention. At follow-up, results showed a reduction in interleukin-6 (SMCD = -.13, 95% CI [-.29 - .03]) and C-reactive protein (SMCD = -.39, 95% CI [-.68 - -.10]) and increase in CD4+ (SMCD = .22, 95% CI [-.08 - .52]). Meta-regression results showed that some heterogeneity in effect size could be accounted for by intervention dosage, study population, and study design. Our findings quantify MBIs' potential for improving immune function and thus impacting somatic disorders.

Comparable studies

Other systematic reviews and meta-analyses on meditation, most cited first.

Study Year Design Participants
Meditation Programs for Psychological Stress and Well-being Diverse adult clinical populations 2014 Meta-analysis n = 3,515
Mindfulness-Based Stress Reduction for Stress Management in Healthy People: A Review and Meta-Analysis Healthy subjects 2009 Systematic review and meta-analysis
The psychological effects of meditation: A meta-analysis. Nonclinical groups of adult meditators 2012 Meta-analysis n = 163
Efficacy of Mindfulness-Based Cognitive Therapy in Prevention of Depressive Relapse Adults with recurrent depression in full or partial remission 2016 Meta-analysis of individual patient data from randomized controlled trials n = 1,258
Mindfulness‐Based Stress Reduction and Mindfulness‐Based Cognitive Therapy – a systematic review of randomized controlled trials 2011 Systematic review

Citations in the library

Cited by 20

and 15 more in the library

Cites 32

and 27 more in the library

Explore topics